Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus
OLLTT
An Open-Label, Long-Term Treatment Study to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane With Subjective Tinnitus
2 other identifiers
interventional
821
14 countries
135
Brief Summary
The purpose of this study is to investigate the long-term safety and tolerability and efficacy of neramexane mesylate in the long-term treatment of subjective tinnitus after a completed double-blind randomized placebo controlled study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Jan 2009
Typical duration for phase_3
135 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedFirst Submitted
Initial submission to the registry
January 21, 2009
CompletedFirst Posted
Study publicly available on registry
January 22, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedNovember 28, 2012
November 1, 2012
2.9 years
January 21, 2009
November 27, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Descriptive analyses of TBF-12 (Tinnitus-Beeinträchtigungs-Fragebogen 12 "Tinnitus Handicap Inventory 12")total score and its subscores, of the Tinnitus Rating Scale and its single items as well as of SF-36 and safety/tolerability parameters
54 weeks
Study Arms (1)
1, verum
EXPERIMENTALInterventions
Up-titration treatment period of 5 weeks up to 75mg Neramexane mesylate oral per day followed by 49 weeks treatment maintenance
Eligibility Criteria
You may qualify if:
- Male or female patients who have successfully completed one of the double-blind Phase 3 tinnitus studies of Merz with Neramexane mesylate
- patients aged equal or older 18 but not older than 75 years with clinical diagnosis of first onset, persistent (i.e. tinnitus should never be absent for more than 24 hours in a row), subjective, uni-or bilateral subacute tinnitus at the timepoint of the lead-in study
You may not qualify if:
- clinical diagnosis of intermittent or pulsatile tinnitus
- Patients who have tinnitus as a concomitant symptom of an otological/neurological disease (such as otitis media, Meniére´s disease, otosclerosis etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (135)
Paradigm Clinical Research
Tucson, Arizona, 85705, United States
Providence Clinical Research
Burbank, California, 91505, United States
Central California Clinical Research
Fresno, California, 93720, United States
UC Davis Health System Department of Otolaryngology
Sacramento, California, 95817, United States
Colorado Otolaryngology Associates
Colorado Springs, Colorado, 80909, United States
New West Physicians
Golden, Colorado, 80401, United States
Visions Clinical Research
Boynton Beach, Florida, 33472, United States
Clinical Research of West Florida
Tampa, Florida, 33603, United States
Deerpath Physicians Group
Gurnee, Illinois, 60031, United States
Knight Center for Integrated Health,
Peoria, Illinois, 61614, United States
University of Kansas Department of Otolaryngology Head & Neck Surgery
Kansas City, Kansas, 66160-0001, United States
Heartland Research Associates, LLC.
Wichita, Kansas, 67205, United States
Heartland Research Associates, LLC.
Wichita, Kansas, 67207, United States
Commonwealth Ear, Nose & Throat
Louisville, Kentucky, 40207, United States
Glacier Ear, Nose, and Throat, Head and Neck Surgery, P.C.
Kalispell, Montana, 59901, United States
Immedicenter
Bloomfield, New Jersey, 07003, United States
David L. Bortniker, M.D, FACS
Somerville, New Jersey, 08876, United States
Erie County Medical Center, Department of Rehabilitation Medicine
Buffalo, New York, 14221, United States
Montefiore Medical Center Attn: Anxiety and Depression Center
The Bronx, New York, 10867, United States
Cary Medical Research
Cary, North Carolina, 27518, United States
Wake Research Associates, LLC
Raleigh, North Carolina, 27612, United States
Wilmington Medical Research
Wilmington, North Carolina, 28401, United States
Piedmont Medical Research
Winston-Salem, North Carolina, 27103, United States
Medical University of South Carolina - Department of Otolaryngology, Department of Otolaryngology - Head & Neck Surgery
Charleston, South Carolina, 29425-5500, United States
Future Search Trials of Neurology
Austin, Texas, 78756, United States
FutureSearch Trials of Dallas
Dallas, Texas, 75231, United States
R/D Clinical Research, Inc.
Lake Jackson, Texas, 77566, United States
South Texas Research Alliance LLC
Laredo, Texas, 78041, United States
Research Across America
Plano, Texas, 75093, United States
Advanced Clinical Research
West Jordon, Utah, 84088, United States
Health Research of Hampton Roads, Inc.
Newport News, Virginia, 23606, United States
Krankenhaus der Elisabethinen
Graz, 8020, Austria
Bezirkskrankenhaus Kufstein Dr. Christof Pauli (PI: Prim. Dr. Peter Ostertag
Kufstein, 6330, Austria
Clin Pharm International GmbH, Zentrum Wien
Vienna, 1090, Austria
University Hospital Brussels
Brussels, 1090, Belgium
Clinique Universitaire Saint-luc
Brussels, 1200, Belgium
AZ Sint Lucas, ENT department
Ghent, 9000, Belgium
University Hospital Leuven, ENT Department
Leuven, 3000, Belgium
Consultório Dr. Marcelo Rates
Belo Horizonte/Mimaf Gerais, CEP 30150-270, Brazil
Osmar Clayton Person
Santo André/SP, zip 09060-650, Brazil
Instituto Ganz Sanchez
São Paulo/SP, ZIP CODE: 05469-000, Brazil
Clínica OTOSUL
Valenca/RJ, CEP.: 27211-130, Brazil
Medico
Chodov, Prague, 4, Czechia
prof. MUDr. Ivo Šlapák
Brno, 602 00, Czechia
Teaching University Hospital, ORL klinika
Brno, 65691, Czechia
ORL oddělení, Karlovarská krajská nemocncie a.s.
Karlovy Vary, 360 66, Czechia
Oblastní nemocnice Kladno a.s., Nemocnice Středočeského kraje
Kladno, 272 59, Czechia
Pro-audio,s.r.o.-private ENT clinic
Mladá Boleslav, 29301, Czechia
ORL oddělení, Všeobecná Fakultní Nemocnice v Praze
Prague, 128 08, Czechia
ORL oddělení , Karlovarská krajská nemocnice a. s.
Sokolov, 356 01, Czechia
Dr. Ebbo
Issy-les-Moulineaux, 92130, France
Dr. Sarfati
La Seyne-sur-Mer, 83500, France
Centre Hospitalier de Bretagne Sud Service ORL-B9
Lorient, 2233-56322, France
Dr. Bonfils
Paris, 75015, France
Dr. Ohresser
Paris, 75015, France
Hopital Nord
Saint-Etienne, 42055, France
Dr. Fraysse
Toulouse, 31059, France
Service ORL CHU Bretonneau
Tours, 37044, France
Hopital Paul BROUSSE Polyclinique
Villejuif, 94800, France
Dr. Kühne, Elisabeth
Halle, Saale, 06112, Germany
Dr. med. Norbert Pasch
Aachen, 52074, Germany
Charité, Universitätsmedizin Berlin-Tinnituszentrum
Berlin, 10117, Germany
Klin. Forschung Berlin Buch GmbH
Berlin, 13125, Germany
Dr. med. Frank Reintjes
Braunschweig, 38100, Germany
DM Helena Sigal
Chemnitz, 09120, Germany
Dr. Klaus Peter Jayme
Darmstadt, 64283, Germany
Dr. Christian Dörr
Dresden, 01277, Germany
HNO-Praxis im Gesundheitszentrum
Duisburg, 47179, Germany
Dr. Gieselmann, Werner
Heiligenhaus, 42579, Germany
Dr. Wolfgang Lotte
Iserlohn, 58642, Germany
Dr. Dr. med. Hans-Detlev Stahl
Leipzig, 04103, Germany
HNO Praxis
Lichtenfels, 96215, Germany
Dr. Dannesberger
Lorsch, 64653, Germany
ClinPharm International
Magdeburg, 39104, Germany
HNO Gemeinschaftpraxis
Meppen, 48716, Germany
Martin Canis, MD
Munich, 81377, Germany
Dr. med. Ulrike Walter
Nuremberg, 90402, Germany
Dr. Susanne Wiedemann
Nuremberg, 90443, Germany
Dr. Norbert Staab
Schlüchtern, 36381, Germany
Dr. Hannelore Neumaier
Wiesbaden, 65183, Germany
Unidad Médica de Especialidades del Noroeste (UMEN)
Centro Culiacán Sinaloa, 80000, Mexico
Hospital General de Chihuahua. "Dr. Salvador Anchondo"
Chihuahua C.P. 31000, Mexico
Hospital Christus Muguerza del Parque
Chihuahua CP 3100, Mexico
Internal Medicine Clin Trials (IMED)
Col Obispado, Monterrey , N.L. C.P. 64060, Mexico
Hospital Civil de Guadalajara
Col. El Retiro CP 44280 Cuadalajara Jalis, Mexico
Grupo Médico Terranova
CP 44630 Guadalajara Jalisco, Mexico
Clinical Research Instutute S.C.
Edo. de México CP 54055, Mexico
Instituto Biomédico de Investigación A.C.
Fracc. Bosques Del Prado Norte Aguascalientes, CP 20127, Mexico
Unidad de Investigación Clínica Cardiometábolica de Occidente S.C. (UNICAMO)
Jalisco, Mexico
Monterrey International Research Center (MIRC)
Nuevo León CP 64000, Mexico
Hospital Universitario Dr. José Eleuterio González. Edificio Elizondo Barragán, Servicio de Otorrinolaringología
Nuevo León CP 64400, Mexico
Hospital Central "Dr. Ignacio Morones Prieto" Servicio de Otorrinolaringología
San Luis Potosí, SLP, México, 78240, Mexico
Andromed Zoetermeer
Zoetermeer, EK, 2724, Netherlands
Andromed Oost
Velp, ES, 6883, Netherlands
Rijnland Ziekenhuis, ENT department
Leiderdorp, GA, 2353, Netherlands
Andromed Rotterdam
Rotterdam, HC, 3021, Netherlands
Adromed Nijmegen
Nijmegen, HL, 6533, Netherlands
Andromed Leiden
Leiderdorp, RA, 2352, Netherlands
Andromed Breda
Breda, VL, 4811, Netherlands
Uniwersytecki Szpital Kliniczny w Bialymstoku
Bialystok, 15-276, Poland
Niepubliczny Zaklad Opieki Zdrowotnej Prywatne Centrum Medyczne PROMEDIS
Gdansk, 80-288, Poland
Szpital Miejski im. J.Brudzinskiego
Gdynia, 81-348, Poland
Samodzielny Publiczny Szpital Kliniczny im. Andrzeja Mieleckiego Slaskiego Uniwersytetu Medycznego w Katowicach
Katowice, 40-027, Poland
NZOZ Specjalistyczne Centrum Medyczne Nowomed
Krakow, 30-349, Poland
Niepubliczny Zaklad Opieki Zdrowotnej PROMED
Krakow, 31- 636, Poland
Specjalistyczny Gabinet Otolaryngologiczny
Krakow, 31-534, Poland
Szpital Specjalistyczny im. Stefana Zeromskiego, SP ZOZ w Krakowie, Oddzial Otolaryngologii
Krakow, 31-913, Poland
Samodzielny Publiczny Zaklad Opieki Zdrowotnej, Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi
Lodz, 91-153, Poland
Wojewodzki Szpital Specjalistyczny im. Stefana Kardynała Wyszynskiego Samodzielny Publiczny Zaklad Opieki Zdrowotnej
Lublin, 20-718, Poland
Wojewodzki Szpital Specjalistyczny w Olsztynie
Olsztyn, 10-561, Poland
Instytut Fizjologii i Patologii Sluchu
Warsaw, 01-943, Poland
Samodzielny Publiczny Szpital Kliniczny nr 1 we Wroclawiu
Wroclaw, 50-369, Poland
Hospital Militar Regional nº 1 Serviço de Otorrinolaringologia
Porto, 4050-113, Portugal
Louis Leipoldt Mediclinic
Bellville, 7530, South Africa
Lakeview Hospital
Benoni, 1501, South Africa
1007 Louis Pasteur Building
Pretoria, 0002, South Africa
GCT Eastmed Clinical Trial centre
Pretoria, 0186, South Africa
Constantiaberg Medi Clinic,
Western Cape, 7800, South Africa
Prince Alfred House
Wynberg, 7800, South Africa
Hospital Sagunto
Sagunto, Valencia, 46520, Spain
Fundación Hospital de Alcorcón, Otorhinolaryngology
Alcorcon - Madrid, 28922, Spain
Hospital Clínico Barcelona, Dept. Of ORL
Barcelona, 08036, Spain
Hospital Puerta del Hierro, Madrid- Servicio de ORL
Madrid, 28035, Spain
Hospital Universitario Príncipe de Asturias
Madrid, 28805, Spain
Clínica Universitaria de Navarra, Dept. ORL
Pamplona, Navarra, 31008, Spain
Hospital Universitario de Salamanca- Hospital Virgen de la Vega
Salamanca, 37007, Spain
Oldfield Surgery
Bath, BA2 3HT, United Kingdom
Addenbrooke's Hospital
Cambridge, CB2 2QQ, United Kingdom
Avondale Surgery, Research Office
Chesterfield, S40 4TF, United Kingdom
The university Hospitals of Leicester, Leicester Royal Infirmary
Leicester, LE1 5WW, United Kingdom
Burbage Surgery
Leicestershire, LE10 2SE, United Kingdom
The Freeman Hospital
Newcastle upon Tyne, NE7 7DN, United Kingdom
Wansford and Kings Cliffe Practice
Petereborough, PE8 6PL, United Kingdom
Frome Medical Practice
Somerset, BA11 1EZ, United Kingdom
Sherbourne Medical Centre
Warwickshire, CV32 4RA, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Medical Expert
Merz Pharmaceuticals
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 21, 2009
First Posted
January 22, 2009
Study Start
January 1, 2009
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
November 28, 2012
Record last verified: 2012-11